previously showed that prolonged exposure of differentiated astrocytes to Transforming Growth Factor (TGF ), a member of the α Epidermal Growth factor (EGF) family , results in their progressive and functional reversion, first to neural progenitor-like cells akin to 7 radial glia, and then to cells that exhibit properties of neural stem cells . TGF and its receptor erbB1 (or epidermal growth factor 8 α receptor, EGFR) are involved in the control of both gliogenesis and glioma development. They constitute the signaling module most frequently deregulated in gliomas. TGF over-expression is found in about 80 of gliomas, and is observed from the initial steps of their α % development , whereas the over-expression of erbB1 appears in 20 40 of gliomas in later phases . Over-expression of TGF and/or 9 -% 10 α its receptor are, by themselves, insufficient to achieve cancerous transformation of astrocytes in transgenic mice , . 11 12 In the context of regenerative medicine, the ability to revert somatic cells to an embryonic state without nucleic acid delivery of reprogramming factors , and with a single modification of their environment is of great interest. This interest is reinforced by the 13 14 8 recent report that a subset of reactive astrocytes isolated from the brains of stab wound-injured mice may reacquire, at least , neural in vitro stem cell properties , and by the known over-expression of TGF by reactive astrocytes (reviewed in ). In light of the deregulation of 15 α 9 TGF expression in the early stages of glioma development, it is important to determine whether reversion of astrocytes to a neural α progenitor state predisposes the cells to cancerous transformation. To evaluate this possibility, we used a classical mutagenic treatment, irradiation, to determine whether astrocytes de-differentiated into progenitor-like cells are more sensitive to cancerous transformation than their mature counterparts. Our results show that mature astrocytes, having regressed to a neural progenitor-like stage in response to a single change in their extra-cellular environment, can be the cell of origin of gliomas.
Materials and methods

Animals
C57Bl6/J and Nude mice (Charles River, France) were housed in an air-conditioned room with free access to water and food. NOD/SCID mice (Charles River, France) were maintained in microisolator cages in pathogen-free conditions.
Cell culture and irradiation
Cultures of mouse astrocytes were prepared from cortices of 1-to-2-day-old C57Bl6/J mice as previously described . Briefly, 16 cultures were established in defined MEM:F12 medium containing 10 fetal calf serum (Biowest, Nuaill , France). Medium was changed astrocyte culture lysates were determined using an anti-human TGF sandwich ELISA (R&D systems, France) following the manufacturer α s instructions. Assays of erbB1 levels and activation were performed as previously described with the following antibodies: anti-erbB1
sc-03-G from Santa-Cruz (TEBU, France) for immuno-precipitation, anti-erbB1 and anti-phosphotyrosine antibody 4G10 from UpstateBiotechnologies (Lake Placid, NY) for immuno-blotting. Expression of TACE, the enzyme that controls TGF release from the α cells , was verified using Western blot analysis with an anti-TACE antibody from Santa-Cruz (1:250, sc-6416, TEBU, France), as 17 previously described . 18
Astrocytes cultivated with or without TGF were irradiated with 5 Gy of -radiation using a Cs irradiator (IBL 637, Institut Curie, throughout the experime ntal procedure, except during irradiation, which was performed at 20 C in ambient a ir. Two hours after°i rradiation, the cells were washed with ice-cold PBS, and further cultured in their original medium with changes of media every 3 days. In addition, astrocytes cultivated with or without TGF were treated with 1 M Tyrphostin AG1478 (La Jolla, CA) between minus 2, and α μ plus 2 hours of the irradiation time-point. AG1478 is a specific inhibitor of erbB1 tyrosine kinase activity , known to inhibit TGF 19 α effects on astrocytes , . 8 20
Changes in morphology or growth pattern were verified by visual inspection prior each medium renewal. After 40 DIV, medium was switched to a 1:1 mixture of DMEM and F12 nutrient (Invitrogen, France), containing 0.6 glucose, 2 mM glutamine, 13 mM sodium % bicarbonate, 5 mM N-2-hydroxyethylpiperazine-N -2-ethanesulfonic acid (HEPES) buffer, 5 IU/ml penicillin and 5 g/ml streptomycin,
and B27, N-2 and G5 supplements (10 l/ml each, Invitrogen) (NS34 medium, ). This medium was renewed once per week. Experiments μ 8 were repeated three times in an independent manner.
Proliferation and survival assays
Seventy days post-irradiation, cultures were trypsinised and counted. Cell viability was determined by Trypan Blue exclusion. To construct growth curves, cultures were submitted to serial passages when reaching 70 90 confluence.
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Array CGH
The samples were homogenized, and genomic DNA was extracted according to Qiagen protocols with modifications. 
Anchorage-independent Growth assays
The cells (10,000) were uniformly suspended in 1.5 ml NS34 containing 66 methylcellulose medium (M3434; Stem Cell % Technologies, France). The suspension was plated in 35 mm dishes. The plates were incubated at 37 C in a 5 CO humidified°% 2 atmosphere after microscopic evaluation to ascertain that no cellular clusters have been seeded. The cells were cultured for 7 days prior to the evaluation of colony formation.
Subcutaneous and intracerebral grafting
Cell suspensions in PBS were prepared prior to grafting from cultures treated with trypsin. Bilateral subcutaneous injections of either 5.10 or 5.10 -cells/200 l were performed into the flanks of 6-week-old NOD/SCID mice (n 10). Mice were screened twice weekly for 
Results
Irradiation immortalizes astrocytes de-differentiated into progenitor-like cells
Astrocytes maintained for a week in serum-free medium exhibit a flat, polygonal morphology ( ), while TGF -treated ). In contrast, TGF -treated cultures survived beyond 3 weeks regardless of whether they had been irradiated ( ).
Non-irradiated TGF -treated astrocytes presented the previously described radial glia-like bipolar morphology , with a thin layer of Blockade of erbB1 signaling had no effect on the survival of control or TGF -treated astrocytes up to 40 days post-irradiation, the α longest time point surveyed. To verify whether TGF promoted DNA double-strand break repair or survival, we added the growth factor α to control cultures within 30 minutes after their irradiation. Surprisingly, all cells died within 6 days, demonstrating that TGF potentiates α irradiation-triggered cellular stress.
Taken together, these results indicate that radioresistance of astrocytes, irrespective of whether they have been previously treated with TGF , is independent from the erbB1-signalling pathway. ).
-
Fig. 3b
Most of the tumors had developed beyond the subcutaneous space, and some grew within the peritoneal cavity. Histological analysis showed that the tumors were formed of bundles of spindle-shaped cells, and contained areas of pseudopalissading necrosis ( ). They Fig. 3c were highly destructive of the host tissues, as illustrated for the dermis ( ), the cartilages ( ), and the muscles ( ). Their Fig. 5g the brain tumor core ( ). Finally, no GFAP-immunoreactive tumor cells were observed in subcutaneous tumors (  Fig. 5h Supplementary Fig.   ) . Conversely, no cells expressing the neuronal marker synaptophysin were observed in CNS tumors ( ) while 1b Supplementary Fig. 1d numerous synaptophysin-immunoreactive cells were observed within the subcutaneous tumors ( ). These data Supplementary Fig. 1c indicate that the environment influences the molecular markers of the tumor cells, without affecting their tumorigenicity.
Taken together, these results demonstrate that irradiation triggered cancerous transformation of astrocytes if they had regressed to a progenitor-like status upon TGF action. Table 1 astrocytes maintained in serum-free medium were highly similar to those for TGF -treated astrocytes. Both cell types exhibited α polymorphisms compared with the control DNA sample provided by the manufacturer, most notably in chromosome 4qD1 ( , Fig. 6a ). A search for genomic imbalances appearing de novo in transformation was performed through the comparison of supplementary Table 1 array CGH patterns of the samples. The profiles of irradiated TGF -treated astrocytes growing either in the form of adherent ( ) or floating cells (not shown) were very similar ( ), and differed from non-irradiated cultures most prominently through gains in Table 1 chromosomes 6qA-E, 7qA-F, 11qB-E and 15qA-F ( and ). Irradiated TGF -treated astrocytes that grew as floating cells CNAs on chromosome 7, whereas 2 other tumors exhibited CNAs only on chromosome 7qA1-B3 ( ). The profiles of tumors Table 1 generated from TGF -treated astrocytes growing as adherent cells exhibited a remarkable degree of similarity ( ). The most notable α Table 1 variation was seen in the 7qF1-F5 CNAs, present in irradiated TGF -treated astrocytes growing as adherent cells and in all but one tumor α generated from these cells (n 5).
=
These results show that irradiation-induced cancerous transformation of TGF -treated astrocytes was accompanied by the acquisition α of several CNAs, among which those located on chromosomes 6, 7 and 11 were conserved among all irradiated cells , and all in vitro tumors . Interestingly, gains in chromosome 6 and 11 segments encompassed the loci of the TGF gene and the erbB2 in vivo α proto-oncogene, an orphan receptor of the erbB1 family, respectively. No segmental alterations were observed in gene loci encoding other members of the EGF and erbB families, erbB1 included. Additional molecular and pharmacologic studies are required to determine which molecular pathways are instrumental in radiation-induced neoplastic transformation of these cells, and in the maintenance of their tumorigenicity.
Discussion
Our results demonstrate that, unlike mature astrocytes, those that revert to neural progenitor-like cells upon TGF action can be is independent of secondary alterations selected . In addition, the lack of genomic anomalies in TGF -treated astrocytes prior to in vivo 
Conclusion
Our results show that regression of astrocytes to a progenitor-like stage sensitizes the cells to oncogenic events. Immediate exposure of irradiated-astrocytes to TGF kills them instead of promoting their cancerous transformation. This further shows that the change in the α differentiation status of the astrocytes is a prerequisite condition to their cancerous transformation. Whether this sensitization is of the same magnitude for artificial and natural progenitors remains to be determined. It is indeed possible to envisage that de-differentiated In any case, our results suggest that the frequent TGF over-expression observed at the early stages of glioma development testifies to α a participation of this growth factor in the earliest pathological events that result in glioma induction.
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Figure 5
Immunohistochemical characterization of irradiated TGF -treated astrocytes in vitro and after intra-cerebral grafting. Most astrocytes α a.
de-differentiated into progenitor-like cells upon TGF action and transformed by irradiation express the astroglial marker GFAP. Patches 
Figure 6
Profile of gains and losses of irradiated TGF -treated astrocytes growing in the form of adherent cells (red), compared with their a. α non-irradiated sister cells (grey), and non-irradiated astrocytes maintained in serum-free medium (black). Shown are log 2 ratios for each chromosome. Non-irradiated astrocytes exhibited the same profile irrespective of exposure to TGF . Irradiated TGF -treated astrocytes 
